Nancy Sabin (l) and Nathaniel Sisitsky.

  
LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), developer, manufacturer and marketer of the EVO family of implantable collamer lenses (EVO ICL) for myopia, astigmatism and presbyopia, has announced that Nancy Sabin has been named chief marketing officer and Nathaniel Sisitsky has been named general counsel. Both will serve on the company’s executive committee and report to Tom Frinzi, STAAR Surgical’s president and CEO, according to the announcement. “We are thrilled to strengthen the STAAR team with the addition of Nancy and Nate, two seasoned executives with extensive senior leadership experience," Frinzi said.

"They will play an integral role in accelerating our momentum and thereby growing the market for our surgeon customers who provide patients visual freedom from contact lenses and glasses with our lens-based technology. I would like to express my utmost gratitude to Sam Gesten, STAAR’s former general counsel, who retired after 12 years of service earlier this year. We are grateful for his tireless work in moving the company forward and wish him all the very best in the future.”

Sabin joined the team from Johnson & Johnson (J&J), where she most recently served as VP of marketing and connected commerce for J&J Vision, managing based marketing, digital strategy and connected commerce functions for the Acuvue contact lens business in the U.S.

 
“I am delighted to be a part of STAAR during this critical phase in the company's growth,” Sabin said. "I am a huge believer in the transformation made possible thanks to our EVO ICLs and look forward to elevating the STAAR and EVO brands among surgeons and their patients. I am excited and honored to lead our marketing teams worldwide."

Sisitsky joined STAAR Surgical from NuVasive, Inc., a medical device company, where he served as senior vice president, general counsel and corporate secretary since 2018.

“I am thrilled to join the STAAR leadership team at a time of significant opportunity and growth for our vision correction lenses,” Sisitsky said.